Lynside® Pro GI+ Reduces IBS Pain

LAS VEGASConsuming Lesaffre Human Cares new probiotic yeast, Lynside® Pro GI+, reduced abdominal pain or discomfort in the Lille, France-based companys 200-person clinical trial. Benoit Laplaize, global sales and marketing manager for Lesaffre Human Care, will present this study as well as the new ingredient at a SupplySide West VendorWorks session on Thursday, Oct. 21 from 2:30 to 3:20 p.m. at the show-floor presentation area, #10068.

There are only a few clinical studies on the efficacy of probiotics in relieving irritable bowel syndrome (IBS) symptoms, and those studies were conducted with a small number of subjects," Laplaize said. The results of those studies lack consistency and statistical significance. Lesaffres 200 IBS-patient study showed that consuming 500mg of Lynside® Pro GI+ per day is well-tolerated and reduces abdominal pain or discomfort after taking Pro GI+ for four weeks."

IBS, a relapsing functional intestinal disorder commonly characterized by abdominal pain or discomfort, bloating, distension and disordered defecation such as diarrhea and/or constipation, affects about 20 percent of the American population.       

For more than 150 years, Lesaffre has been manufacturing yeast and yeast derivatives. The U.S. Human Care division focuses exclusively on marketing yeast products that advance human health by nature of their overall nutritional value or condition-specific health benefits. For manufacturers, Lesaffre offers a variety of yeast ingredients under the LYNSIDE® brand for use in functional foods, dietary supplements, cosmetics and clinical nutrition.